N. Tyagarajan V - 03 May 2023 Form 4 Insider Report for Genpact LTD (G)

Role
President and CEO, Director
Signature
/s/ Thomas D. Scholtes, as Attorney-in-fact for N.V. Tyagarajan
Issuer symbol
G
Transactions as of
03 May 2023
Net transactions value
-$2,295,748
Form type
4
Filing time
05 May 2023, 16:10:29 UTC
Previous filing
03 May 2023
Next filing
18 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction G Common Shares Options Exercise $967,500 +50,000 +6.2% $19.35 855,509 03 May 2023 Direct F1
transaction G Common Shares Sale $2,169,285 -50,000 -5.8% $43.39 805,509 03 May 2023 Direct F1, F2
transaction G Common Shares Options Exercise $967,500 +50,000 +6.2% $19.35 855,509 04 May 2023 Direct F1
transaction G Common Shares Sale $1,970,419 -47,830 -5.6% $41.20 807,679 04 May 2023 Direct F1, F3
transaction G Common Shares Sale $91,044 -2,170 -0.27% $41.96 805,509 04 May 2023 Direct F1, F4
holding G Common Shares 10,000 03 May 2023 By Trust F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction G Employee Stock Option (Right to Buy) Options Exercise $0 -50,000 -17% $0.000000 250,000 03 May 2023 Common Shares 50,000 $19.35 Direct F6
transaction G Employee Stock Option (Right to Buy) Options Exercise $0 -50,000 -20% $0.000000 200,000 04 May 2023 Common Shares 50,000 $19.35 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022.
F2 The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.052 to $43.85. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $40.83 to $41.77. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $41.87 to $42.02. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein.
F6 The option vested 50% on January 10, 2016 and the remainder on January 10, 2018.